| View |
|
DRP-14019-01
|
Co-Amoxiclav
|
Comoxbet
|
457 mg/ 5 mL
|
Powder for Suspension
|
Antibacterial (Penicillins)
|
Indchemie Health Specialities Private Limited
|
India
|
CLIDP Conversion
|
27 December 2023
|
06 June 2028
|
| View |
|
DRP-14088-01
|
Tobramycin (as sulfate) + Dexamethasone (as sodium phosphate)
|
Combidar
|
3 mg / 1 mg (0.3 % / 0.1 % w/v) per mL Sterile
|
Ophthalmic Suspension (Eye Drops)
|
Antibacterial (Aminoglycoside) / Corticosteroid
|
Makcur Laboratories Limited
|
India
|
CLIDP Conversion
|
20 December 2023
|
20 June 2028
|
| View |
|
DRP-14088-02
|
Tobramycin (as sulfate) + Dexamethasone (as sodium phosphate)
|
None
|
3 mg/1 mg (0.3% / 0.1% w/v) per mL Sterile Ophthalmic
|
Suspension (Eye Drops)
|
Antibacterial (Aminoglycoside) / Corticosteroid
|
Makcur Laboratories Limited
|
India
|
CLIDP Conversion
|
31 December 2023
|
20 June 2028
|
| View |
|
DRP-14088-03
|
Tobramycin (as sulfate) + Dexamethasone (as sodium phosphate)
|
Tobdex Free
|
3 mg/1 mg (0.3% w/v / 0.1% w/v) per mL Sterile
|
Ophthalmic Suspension (Eye Drops)
|
Antibacterial (Aminoglycoside) / Corticosteroid
|
Makcur Laboratories Limited
|
India
|
CLIDP Conversion
|
31 December 2023
|
20 June 2028
|
| View |
|
DRP-14088-04
|
Tobramycin (as sulfate) + Dexamethasone (as sodium phosphate)
|
Aguadexa
|
3 mg / 1 mg (0.3 % /0.1 % w/v) per mL Sterile
|
Ophthalmic Suspension (Eye Drops)
|
Antibacterial (Aminoglycoside) / Corticosteroid
|
Makcur Laboratories Limited
|
India
|
CLIDP Conversion
|
04 January 2024
|
20 June 2028
|
| View |
|
DRP-14096-01
|
Clindamycin (as phosphate)
|
Clindex-600
|
150 mg/mL
|
Solution for Injection (IM/IV)
|
Antibacterial (Lincosamide)
|
Makcur Laboratories Limited
|
India
|
CLIDP Conversion
|
27 December 2023
|
20 June 2028
|
| View |
|
DRP-14373-01
|
Cilostazol
|
None
|
100 mg
|
Tablet
|
Antithrombotic Agent (Platelet aggregation inhibitor)
|
Cooper Pharma Limited
|
India
|
CLIDP Conversion
|
02 January 2024
|
30 August 2028
|
| View |
|
DRP-14440-01
|
Dabigatran Etexilate (as mesilate)
|
Amgathran-150
|
150 mg
|
Capsule
|
Direct Thrombin Inhibitor
|
Stallion Laboratories Pvt. Ltd
|
India
|
CLIDP Conversion
|
02 January 2024
|
05 September 2028
|
| View |
|
DRP-14442-01
|
Dabigatran Etexilate (as mesilate)
|
Amgathran-75
|
75 mg
|
Capsule
|
Direct Thrombin Inhibitor
|
Stallion Laboratories Pvt. Ltd
|
India
|
CLIDP Conversion
|
02 January 2024
|
05 September 2028
|
| View |
|
DRP-14442-02
|
Dabigatran Etexilate (as mesilate)
|
Dabbtrann-75
|
75 mg
|
Capsule
|
Direct Thrombin Inhibitor
|
Stallion Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
02 January 2024
|
05 September 2028
|
| View |
|
DRP-14484-01
|
Potassium citrate
|
Citrapos XR
|
1.620 g (15 mEq)
|
Extended-Release Tablet
|
Antiurolithic
|
Cooper Pharma Limited
|
India
|
CLIDP Conversion
|
27 December 2023
|
12 September 2028
|
| View |
|
DRP-14528-01
|
Paracetamol
|
Zetavue
|
10 mg/mL (1 g/100 mL)
|
Solution for Injection (IV Infusion)
|
Analgesic/Antipyretic
|
Hebei Tiancheng Pharmaceutical Co., Ltd
|
China
|
CLIDP Conversion
|
02 January 2024
|
02 October 2028
|
| View |
|
DRP-267-10
|
Multivitamins + Iron
|
Fernyx Plus
|
Each Capsule contains:
Thiamine Mononitrate (Vitamin B1) 15 mg
Riboflavin (Vitamin B2) 10 mg
Pyridoxine Hydrochloride (Vitamin B6) 10 mg
Cyanocobalamin (Vitamin B12) 10 mcg
Folic Acid 1 mg
Ferrous Sulfate dried (equivalent to 92mg Elemental Iron) 250 mg
|
Capsule
|
Vitamins/Mineral
|
Lumar Pharmaceutical Laboratory, Inc
|
Philippines
|
Renewal
|
09 November 2024
|
04 November 2029
|
| View |
|
DRP-4116-04
|
Irinotecan Hydrochloride
|
Tropican
|
20 mg/mL
|
Solution for Injection (IV)
|
Antineoplastic (Cell cycle-specific agent)
|
Venus Remedies, Limited
|
India
|
CLIDP Conversion
|
22 December 2023
|
03 November 2027
|
| View |
|
DRP-4874-03
|
Etoricoxib
|
Akticib
|
90 mg
|
Film-Coated Tablet
|
Coxib
|
XL Laboratories Pvt. Ltd
|
India
|
CLIDP Conversion
|
02 January 2024
|
29 October 2028
|
| View |
|
DRP-4887-06
|
Omeprazole
|
None
|
40 mg
|
Delayed Release Capsule
|
Proton Pump Inhibitor
|
XL Laboratories Pvt. Ltd
|
India
|
CLIDP Conversion
|
27 December 2023
|
04 November 2028
|
| View |
|
DRP-5051-04
|
Azithromycin (as dihydrate)
|
Azithrosave
|
200 mg / 5 mL
|
Powder for Suspension
|
Antibacterial (Macrolide)
|
Opal Laboratories (Pvt.) Limited
|
Pakistan
|
CLIDP Conversion
|
22 December 2023
|
10 June 2028
|
| View |
|
DRP-5078-02
|
Losartan Potassium + Hydrochlorothiazide
|
Provizar Plus
|
50 mg / 12.5 mg
|
Film Coated Tablet
|
Angiotensin II Receptor Blocker/Diuretic
|
Shin Poong Pharmaceutical Co., Ltd
|
Korea
|
CLIDP Conversion
|
04 January 2024
|
11 July 2027
|
| View |
|
DRP-5486-01
|
Albendazole
|
Zomithel
|
400 mg
|
Chewable Tablet
|
Antihelmintic (Benzimidazole derivative)
|
Scott-Edil Pharmacia Limited
|
India
|
Renewal
|
29 September 2024
|
27 August 2029
|
| View |
|
DRP-5493-05
|
Etoricoxib
|
Akticib
|
120 mg
|
Film-Coated Tablet
|
Non-Steroidal Anti-Inflammatory Drug/NSAID (Coxib)
|
XL Laboratories Pvt. Ltd.
|
India
|
Renewal
|
21 March 2024
|
28 August 2029
|